BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1409763)

  • 1. GC/MS/MS quantification of 11-dehydrothromboxane B2 in human urine.
    Ferretti A; Flanagan VP; Maida EJ
    Prostaglandins Leukot Essent Fatty Acids; 1992 Aug; 46(4):271-5. PubMed ID: 1409763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the major urinary thromboxane metabolites, 2,3-dinorthromboxane B2 and 11-dehydrothromboxane B2, by gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry.
    Uedelhoven WM; Meese CO; Weber PC
    J Chromatogr; 1989 Dec; 497():1-16. PubMed ID: 2625446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of an enzyme immunoassay for 11-dehydro-thromboxane B(2) in urine: comparison with GC-MS.
    Perneby C; Granström E; Beck O; Fitzgerald D; Harhen B; Hjemdahl P
    Thromb Res; 1999 Dec; 96(6):427-36. PubMed ID: 10632465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microdetermination of 11-dehydrothromboxane B2 in human urine by gas chromatography-selected-ion monitoring.
    Watanabe K; Yamashita K; Ishibashi M; Hayashi Y; Yamamoto S; Miyazaki H
    J Chromatogr; 1989 May; 468():383-94. PubMed ID: 2732290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new method using simple solid phase extraction for the rapid gas-chromatographic mass-spectrometric determination of 11-dehydro-thromboxane B2 in urine.
    Lorenz R; Helmer P; Uedelhoven W; Zimmer B; Weber PC
    Prostaglandins; 1989 Aug; 38(2):157-70. PubMed ID: 2772221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gas chromatographic-mass spectrometric determination of 11-dehydrothromboxane B2 in human urine.
    Weber C; Beetens J; De Clerck F; Tegtmeier F
    J Chromatogr; 1992 May; 577(1):1-7. PubMed ID: 1400727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tandem mass spectrometric determination of 11-dehydrothromboxane B2, an index metabolite of thromboxane B2 in plasma and urine.
    Schweer H; Meese CO; Fürst O; Kühl PG; Seyberth HW
    Anal Biochem; 1987 Jul; 164(1):156-63. PubMed ID: 3674365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of thromboxane B2 in human urine by isotope dilution and negative ion chemical ionization mass spectrometry.
    Meese CO; Fischer C; Thalheimer P; Fürst O
    Biomed Mass Spectrom; 1985 Sep; 12(9):554-9. PubMed ID: 2932184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of urinary 2,3-dinor-thromboxane B2 and thromboxane B2 using bonded-phase phenylboronic acid columns and capillary gas chromatography--negative-ion chemical ionization mass spectrometry.
    Lawson JA; Brash AR; Doran J; FitzGerald GA
    Anal Biochem; 1985 Nov; 150(2):463-70. PubMed ID: 4091270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative liquid chromatography-tandem mass spectrometric analysis of 11-dehydro TXB2 in urine.
    Suzuki N; Hishinuma T; Chiba S; Saga T; Tsukamoto H; Mizugaki M; Goto J
    Prostaglandins Other Lipid Mediat; 2004 Jan; 73(1-2):103-10. PubMed ID: 15165035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of 11-dehydro-2,3-dinorthromboxane B3 in human urine based on the mass spectral properties of 11-dehydrothromboxane B3 and related compounds.
    Ishibashi M; Hishinuma T; Mizugaki M; Hayashi Y; Kagi N; Harima N
    Rapid Commun Mass Spectrom; 1995; Spec No():S116-22. PubMed ID: 8829476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ingestion of marine oil reduces excretion of 11-dehydrothromboxane B2, an index of intravascular production of thromboxane A2.
    Ferretti A; Judd JT; Taylor PR; Nair PP; Flanagan VP
    Prostaglandins Leukot Essent Fatty Acids; 1993 Apr; 48(4):305-8. PubMed ID: 8497491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry.
    Chiabrando C; Pinciroli V; Campoleoni A; Benigni A; Piccinelli A; Fanelli R
    J Chromatogr; 1989 Oct; 495():1-11. PubMed ID: 2613794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid- and liquid-phase extraction for the gas chromatographic-tandem mass spectrometric quantification of 2,3-dinor-thromboxane B2 and 2,3-dinor-6-oxo-prostaglandin F1 alpha in human urine.
    Tsikas D; Gutzki FM; Böhme M; Fuchs I; Frölich JC
    J Chromatogr A; 2000 Jul; 885(1-2):351-9. PubMed ID: 10941682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of acetaminophen (paracetamol) in human plasma and urine by stable isotope-dilution GC-MS and GC-MS/MS as pentafluorobenzyl ether derivative.
    Trettin A; Zoerner AA; Böhmer A; Gutzki FM; Stichtenoth DO; Jordan J; Tsikas D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(23):2274-80. PubMed ID: 21733763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved assay for the quantification of 11-dehydrothromboxane B2 by gas chromatography-mass spectrometry.
    Morrow JD; Minton TA
    J Chromatogr; 1993 Feb; 612(2):179-85. PubMed ID: 8468374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid-phase extraction of urinary 11-dehydrothromboxane B2 for reliable determination with radioimmunoassay.
    Riutta A; Mucha I; Vapaatalo H
    Anal Biochem; 1992 May; 202(2):299-305. PubMed ID: 1519756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microdetermination of 11-dehydrothromboxane B3 in human urine by gas chromatography--selected-ion monitoring using (18O2) analogue as an internal standard.
    Mizugaki M; Hishinuma T; Nakagawa Y; Nakamura H; Nishikawa M; Ishibashi M; Harima N
    Rapid Commun Mass Spectrom; 1995; Spec No():S55-S60. PubMed ID: 8829485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11-Dehydrothromboxane B2: convenient preparation of its stable isotope-labelled analogue for use in quantitative gas chromatography-mass spectrometry.
    Leis HJ; Welz W; Malle E
    J Chromatogr; 1990 Mar; 526(1):169-73. PubMed ID: 2341528
    [No Abstract]   [Full Text] [Related]  

  • 20. Reference intervals and developmental changes in urinary prostanoid excretion in healthy newborns, infants and children.
    Leonhardt A; Busch C; Schweer H; Seyberth HW
    Acta Paediatr; 1992 Mar; 81(3):191-6. PubMed ID: 1511190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.